FDA Approved: BALSALAZIDE DISODIUM — Supplemental Application (Hikma Pharmaceuticals USA Inc.)

View source ↗

Summary

FDA approved a supplemental application for balsalazide disodium from Hikma Pharmaceuticals USA Inc. under ANDA 077806, enabling continued marketing of the gene…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• BALSALAZIDE DISODIUM (balsalazide disodium)

Snippet

SUPPL AP for BALSALAZIDE DISODIUM (BALSALAZIDE DISODIUM)